Natural killer T cells and ulcerative colitis

Abstract Ulcerative colitis (UC) is one of the two major forms of inflammatory bowel disease (IBD). Both innateimmunity and adaptive immunity are aberrant in IBD. The pathogenesis of UC includes abnormal inflammation and immune responses of the digestive tract. Natural killer T (NKT) cells participate in the innateand adaptive immune responses, together with a vast array of cytokines. Recent studies suggested that IL-13, IL5 and IL-4 are involved in the occurrence and the development of UC. Manipulating NKT cells may be a potential strategy to reconstruct the abnormal immune responses in UC. In this review, we explore the roles of NKT cells and cytokines in UC. Additionally, neutralizing antibodiesand inhibitors of cytokines produced by NKT cells or their receptors are also discussed as novel therapeutic choices for UC.